-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III

Symposia: Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Michael P. Ozga, MD1, Qiuhong Zhao, MS2*, Naresh Bumma, MD3, Ashley E. Rosko, MD2, Abdullah Khan, MBBS, MSc4, Srinivas Devarakonda, MD2, Elvira Umyarova, MD5, Don M. Benson Jr., MD6 and Francesca Cottini, MD7

1Comprehensive Cancer Center, The Ohio State University- Comprehensive Cancer Center, Dublin, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Department of Internal Medicine - Hematology, The Ohio State University, Columbus, OH
5Division of Hematology, The Ohio State University, Columbus, OH
6Riney Family Myeloma Center for Research Excellence, The Ohio State University Medical Center, Columbus, OH
7Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH

Sosana Delimpasi, MD1*, Meletios A. Dimopoulos, MD2, Jan Straub, MD3*, Argiris Symeonidis, MD, PhD4, Roman Hájek, MD, PhD5, Cyrille Touzeau, MD, PhD6*, Viralkumar K. Bhanderi, MD7*, Jesus Berdeja, MD8, Petr Pavlíček, MD9*, Jeffrey V. Matous, MD10, Pawel J. Robak, MD PhD11*, Kaveri Suryanarayan, MD12*, Miguel Villareal12*, Dasha Cherepanov, PhD12*, Jaydeep K. Srimani12*, Huilan Yao, PhD12*, Richard Labotka, MD12 and Robert Z. Orlowski, MD, PhD13

1Department of Hematology and Bone Marrow Transplantation Unit, General Hospital Evangelismos, Athens, Greece
2Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
3Department of Internal Medicine - Hematology, University Hospital, Prague, Czech Republic
4Department of Hematology, University General Hospital of Patras, Patras, Greece
5University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
6University Hospital Hôtel Dieu, Nantes, France
7Florida Cancer Specialists, Tallahassee Cancer Center, Tallahassee, FL
8Sarah Cannon Research Institute, Nashville, TN
9Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
10Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, CO
11Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
12Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
13Departments of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Utkarsh Goel, MBBS1*, Charalampos Charalampous, MD1*, Prashant Kapoor, MD1, Moritz Binder, MD, MPH1, Francis K. Buadi, MB1, David Dingli, MD, PhD1, Angela Dispenzieri, MD1, Amie Fonder, PA-C1*, Morie A. Gertz, MD, MACP1, Wilson I. Gonsalves, MD1, Suzanne R. Hayman, MD1, Miriam A. Hobbs, APRN, CNP, DNP1*, Yi L. Hwa, NP1, Taxiarchis Kourelis, MD1, Martha Q. Lacy, MD1, Nelson Leung, MD1,2, Yi Lin, MD, PhD1, Rahma M Warsame, MD1, Robert A. Kyle, MD3, S. Vincent Rajkumar, MD1* and Shaji K Kumar, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Karthik Ramasamy1, Niels Abildgaard, M.D.2, Marie-Christiane Vekemans3*, Barbara Gamberi, MD4*, Angel Ramírez Payer, MD5*, Gillian Millar6*, Annalisa Ansaloni6*, Margaret Atiba-Davies6*, David Bernasconi6*, Torben Plesner7 and Sujith Dhanasiri, MPhil, MSc6*

1Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, United Kingdom
2Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
3Cliniques Universitaires Saint-Luc, Brussels, Belgium
4Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
5Hospital Universitario Central de Asturias, Oviedo, Spain
6Bristol Myers Squibb, Boudry, Switzerland
7Sygehus Lillebælt, Vejle, Denmark

Rayan Kaedbey, MD1, Kevin A Hay, MD, MSc, FRCPC2, Esther Masih-Khan, PhD3*, Moustafa Kardjadj, PhD4*, Arleigh McCurdy, MD, BSc5, Michael P. Chu, MD6, Victor H Jimenez-Zepeda, MD7, Richard Leblanc, MD, FRCPC8, Kevin Song, MD, FRCPC9, Hira S Mian, MD10, Martha L Louzada, MD, MSc11, Michael Sebag, MD, PhD12, Anthony Reiman, MD13*, Darrell J White, MD14, Christopher P. Venner, MD, FRCPC15, Julie Stakiw, MD, FRCPC16, Rami Kotb, MD, FRCPC17, Muhammad Aslam, MD18*, Debra Bergstrom19*, Engin Gul, BSc, MBA20* and Donna E. Reece, MD, FRCPC21

1Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Montreal, QC, Canada
2Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
3Princess Margaret Cancer Centre/ University of Toronto, Toronto, ON, CAN
4Canadian Myeloma Research Group, Toronto, ON, Canada
5Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
6Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada
7Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
8Hopital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
9Division of Hematology, University of British Columbia and Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
10Department of Oncology, McMaster University, Hamilton, ON, Canada
11University of Western Ontario, London Health Sciences Centre, London, ON, Canada
12Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
13Oncology, Saint John Regional Hospital, Saint John, NB, CAN
14Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
15BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
16Saskatoon Cancer Centre, Saskatoon, SK, Canada
17Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
18Allan Blair Cancer Center, Regina, SK, Canada
19Division of Hematology, Memorial University of Newfoundland, St John’s, Newfoundland and Labrador, Canada, St John's, NF, Canada
20University Health Network-PMH, Concord, ON, Canada
21Princess Margaret Cancer Centre, Toronto, ON, Canada

Luca Bertamini, MD1,2*, Jean-Baptiste Alberge, PhD1,2,3*, Habib El-Khoury, MD1,4, David J. Lee, MD2,3,5,6, Ciara Murphy1,2*, Grace Fleming, BS1,2*, Maya I. Davis, BA1,4*, Jacqueline Perry, MPH1*, Christian J. Cea-Curry, BS1,4*, Audrey Pentz, B.Rad(T)7*, Thulisile Hlubi7*, Natalie Smyth, MS8*, D.J. Sakrikar, PhD9*, Mark C. Perkins, PhD10*, Stephen Harding, PhD10, Derek Troske, BS9*, Gad Getz, PhD3*, Timothy R. Rebbeck, PhD1,11*, Maureen Joffe, PhD7*, Catherine R. Marinac, PhD1,11, Nelson Leung, MD12,13, Carl Wenlong Chen, PhD7,14,15* and Irene Ghobrial, MD1,4,16

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Harvard Medical School, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Medicine, Harvard Medical School, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
6Department of Medicine, Massachusetts General Hospital, Boston, MA
7Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa
8Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
9The Binding Site Inc., Rochester, MN
10The Binding Site Inc., Birmingham, United Kingdom
11Harvard T.H. Chan School of Public Health, Boston, MA
12Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
13Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
14National Health Laboratory Service, National Cancer Registry, Johannesburg, South Africa
15Faculty of Health Sciences, University of the Witwatersrand, Sydney Brenner Institute for Molecular Bioscience, Johannesburg, South Africa
16The Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA

Sarah Zhao1*, Cameron Wellard, PhD2*, Zoe McQuilten, MBBS, PhD2*, Elizabeth M. Moore, PhD3*, Erica M. Wood, MBBS, FRACP, FRCPA4, Andrew Spencer5 and Henry Chan6

1Waitemata DHB, North Shore Hospital, Auckland, New Zealand
2School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
3Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
4Monash Haematology, Monash Health, Clayton, VIC, Australia
5Monash University, Melbourne, Australia
6Department of Haematology, Waitemata DHB, North Shore Hospital, Auckland, New Zealand

Brian G.M. Durie, MD1, Annette Lam2*, Mai Ngo3*, Huiling Pei, PhD3* and Eric M. Ammann2*

1Cedars-Sinai Oschin Cancer Center, Los Angeles, CA
2Janssen Global Market Access, Raritan
3Janssen Global Medical Affairs Statistics, Raritan

Jingyu Xu1*, Lingna Li1*, Wenqiang Yan1*, Huishou Fan1*, Jiahui Liu2*, Chenxing Du, MD3*, Shuhui Deng, MD4*, Weiwei Sui4*, Yan Xu, MD2*, Lugui Qiu1 and Gang An, MD5*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, TIANJIN, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Duoduo Zhao1, Christian Rohde, PhD1*, Fengbiao Zhou, PhD1*, Anna Luise Grab, PhD1*, Alexandra M Poos, PhD1*, Lukas John, MD1*, Stefanie Huhn, PhD1*, Marc S Raab, MD1*, Carsten Mueller-Tidow, MD1 and Niels Weinhold, PhD2*

1Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
2Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

Yuan Xia, MD*, Run Zhang, MD*, Yuanyuan Jin, MD*, Qinglin Shi, MBBS*, Yujie Wu, MD*, Jianyong Li, MD and Lijuan Chen*

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Saurabh Zanwar, MBBS1*, Matthew Ho, MBBCh, BAO, PhD2*, Francis K. Buadi, MB3, Sikander Ailawadhi4, Jeremy T. Larsen5*, P. Leif Bergsagel, MD6, Moritz Binder, MD1, Asher Chanan-Khan, MD7, David Dingli, MD, PhD1, Angela Dispenzieri, MD8, Rafael Fonseca, MD9, Morie A. Gertz, MD, MACP8, Wilson I. Gonsalves, MD10, Ronald Go, MD1, Suzanne R. Hayman, MD1, Prashant Kapoor, MD11, Taxiarchis Kourelis, MD1, Martha Q. Lacy, MD12, Nelson Leung, MD13, Yi Lin, MD, PhD11, Eli Muchtar, MD14, Vivek Roy, MD15, Taimur Sher, MD16, Rahma M Warsame, MD11, Amie Fonder, PA-C1*, Miriam A. Hobbs, APRN, CNP, DNP1*, Yi L. Hwa, NP1, Robert A. Kyle, MD17, S. Vincent Rajkumar, MD1* and Shaji K Kumar, MD11

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Mayo clinic college of medicine, Rochester, MN
4Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
5Division of Hematology, Mayo Clinic, Phoenix, AZ
6Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
7Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
8Mayo Clinic, Rochester, MN
9Department of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
10Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
11Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
12Division of Hematology, Mayo Clinic Rochester, Rochester, MN
13Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
14Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
15Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
16Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
17Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN

Alexander Leipold1*, Rudolf Werner2*, Johannes Duell, MD3,4*, Pius Jung5*, Mara John6*, Emilia Stanojkovska7*, Xiang Zhou8,9*, Anna Ruckdeschel, MD10*, Oliver Dietrich11*, Fabian Imdahl11*, Tobias Krammer11*, Andreas Buck, MD12*, Julia Mersi, MD13*, Hermann Einsele, MD13,14, K. Martin Kortuem13,15*, Antoine-Emmanuel Saliba11* and Leo Rasche, MD16*

1Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, Germany
2Klinik und Poliklinik für Nuklearmedizin, University Hospital of Würzburg, Würzburg, Germany
3Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Bavaria, Germany
4Department of Internal Medicine II, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
5University Hospital of Würzburg, Würzburg, Germany
6Mildred Scheel Early Career Center (MSNZ), University Hospital Wuerzburg, Wuerzburg, DEU
7Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, DEU
8Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany
9Department of Internal Medicine II, Division of Oncology and Hematology, Würzburg University Hospital, Würzburg, Germany
10University Hospital Würzburg, Würzburg, DEU
11Helmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany
12Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany
13Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
14Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
15Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
16Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Bayern, Germany

Nikhil Grandhi1*, Lawrence Liu, MD2*, Mei Wang3*, Theodore S. Thomas, MD, MPHS4, Kristen M. Sanfilippo, MD5, Feng Gao, MD, PhD, MPH6*, Graham A Colditz, MD, DrPH7* and Su-Hsin Chang, PhD8*

1Washington University in St. Louis, Saint Louis, MO
2City of Hope National Medical Center, Duarte, CA
3Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, MO
4St. Louis Veterans Affairs Medical Center, Saint Louis, MO
5Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
6Public Health Sciences Division, Washington University School of Medicine, St. Louis, MO
7Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St Louis, MO
8Research Service, St. Louis Veterans Affairs Medical Center, Saint Louis, MO

Sæmundur Rögnvaldsson, MD1,2*, Jon Þórir Oskarsson, MSc3*, Sigrun Thorsteinsdottir, MD, PhD4,5, Elin Ruth Reed4*, Gudrun Asta Sigurdardottir4*, Brynjar Vidarsson, MD2, Pall Torfi Onundarson, MD2, Margret Sigurdardottir, MD2*, Bjarni Agnar Agnarsson, MD2*, Isleifur Olafsson, MD, PhD2*, Ingunn Thorsteinsdottir, MD2*, Signy Vala Sveinsdottir, MD PhD2*, Robert Palmason4,6*, Fridbjorn Sigurdsson, MD7*, Asdis Rosa Thordardottir4*, Elias Eythorsson, MD, PhD8*, Asbjorn Jonsson, MD7*, Runolfur Palsson, MD2,4*, Olafur Skuli Indridason, MD, MHS2*, Thor Aspelund, PhD4*, Gauti Gislason4*, Andri Olafsson4*, Jon Kristinn Sigurdsson4*, Ingigerdur S Sverrisdottir, MD9*, Gudlaug Katrin Hakonardottir4*, Thorir Einarsson Long, MD, PhD6,10*, Ragnar Danielsen, MD2*, Malin Hultcrantz, MD, PhD11, Brian G.M. Durie, MD12, Stephen Harding, PhD13, Ola Landgren, MD14, Thorvardur Jon Love, MD, PhD2,4* and Sigurdur Y Kristinsson, MD, PhD2,4

1Faculty of Medicine, University of Iceland, Reykjavík, Iceland
2Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
3Faculty of Medicine, University of Iceland, Reykjavik, Reykjavik, Iceland
4Faculty of Medicine, University of Iceland, Reykjavik, Iceland
5Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
6Skåne University Hospital, Lund, Sweden
7Akureyri Hospital, Akureyri, Iceland
8Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland
9Sahlgrenska University Hospital, Gothenburg, Sweden
10Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
11Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
12Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
13The Binding Site Inc., Birmingham, United Kingdom
14Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Massimo Offidani, MD1, Carmela Zizzo2*, Serena Rupoli, MD3*, Irene Federici4*, Sonia Morè5*, Alessandra Bossi6*, Valentina Maria Manieri5*, Maria Teresa Petrucci, MD7, Tommaso Caravita DI Toritto, MD, PhD8*, Marino Brunori9*, Alessandro Gozzetti10*, Attilio Tordi11*, Francesca Fazio12*, Chiara Lisi, MD13*, Assunta Melaccio14*, Lucia Ciuffreda15*, Antonietta Pia Falcone16*, Francesca Fioritoni, MD17*, Silvia Gentili, MD18*, Agostina Siniscalchi19*, Fabio Trastulli, MD20*, Laura Corvatta, MD21*, Erika Morsia, MD22*, Attilio Olivieri, MD23* and Giovanni Duro2*

1Hematology Clinic, AOU Ospedali Riuniti di Ancona, Ancona, Italy
2Institute for Research and Biomedical Innovation (IRIB) of the National Research Council of Italy (CNR), Palermo, Italy
3Clinic of Hematology, Ospedali Riuniti di Ancona, Ancona, Italy
4Ospedali Riuniti Ancona, Ancona, ITA
5Hematology Clinic, AOU Ospedali Riuniti Ancona, Ancona, Italy
6AOU Ospedali Riuniti di Ancona, Ancona, Italy
7Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
8UOSD Ematologia ASL Roma 1, Roma, MARSEILLE CEDEX 09, Italy
9Internal Medicine, Ospedale S. Croce, Azienda Ospedaliera Ospedali Riuniti Marche Nord, FANO, ITA
10Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy
11Ospedale Santo Spirito- ASL Roma1, Roma, Italy
12Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Italy, ROMA, Italy
13Ospedale Policlinico Umberto I, Roma, Italy
14Department of Biomedical Sciences and Human Oncology, Unit of Internal Medicine “Guido Baccelli”, University of Bari Aldo Moro Medical School, University of Bari Medical School, Bari, Italy
15Ospedale Cisanello di Foggia, Foggia, Italy
16Unità di Ematologia, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
17Department of Hematology, Transfusion Medicine and Biotechnology, "Santo Spirito" Civic Hospital, Pescara, Italy
18Hematology Unit, Ospedale Generale di Civitanova Marche, Civitanova Marche, Italy
19UOSD San Filippo Neri, Roma, Italy
20Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
21Ospedale E. Profili Fabriano, Fabriano, Italy
22Ospedali Riuniti di Ancona, Clinic of Hematology, Ancona, Italy
23Università Politecnica Delle Marche, Ancona, Italy

Alankrita Taneja, MBBS1, Katy Wang, M.A.1*, Sarah Parker1*, Sheeba Ba Aqeel, MD1, Joseph D. Tario Jr., PhD2*, Hassan Awada, MD1*, Arya Roy, MD1*, Maximilian Merz, MD3, Philip L. McCarthy, MD1 and Jens Hillengass, MD, PhD1

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Flow Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

Ingigerdur S Sverrisdottir, MD1,2*, Sigrún Thorsteinsdóttir, MD, PhD2,3, Sæmundur Rögnvaldsson, MD4*, Thor Aspelund, PhD2*, Brynjar Vidarsson, MD5, Páll Torfi Önundarson, MD5*, Bjarni Agnarsson, MD5*, Margrét Sigurdardóttir, MD5*, Ingunn Thorsteinsdottir, MD5*, Signy Vala Sveinsdottir, MD PhD5*, Robert Palmason2,6*, Ísleifur Ólafsson, MD, PhD5*, Fridbjorn Sigurdsson, MD5*, Ásdis Rósa Thórdardottir2*, Elias Eythorsson, MD, PhD5*, Asbjorn Jonsson, MD5*, Runolfur Palsson, MD2,5*, Olafur Skuli Indridason, MD, MHS2,5*, Gauti Kjartan Gislason, MSc2*, Andri Olafsson2*, Jon Kristinn Sigurdsson2*, Hlif Steingrimsdottir, MD5*, Thorir Einarsson Long, MD, PhD2,6*, Malin Hultcrantz, MD, PhD7, Brian G.M. Durie, MD8, Stephen Harding, PhD9, Ola Landgren, MD10, Sigurdur Y Kristinsson, MD, PhD2,5 and Thorvardur Jon Love, MD, PhD2,5*

1Sahlgrenska University Hospital, Gothenburg, Sweden
2Faculty of Medicine, University of Iceland, Reykjavik, Iceland
3Rigshospitalet, Copenhagen, Denmark
4Faculty of Medicine, University of Iceland, Reykjavík, Iceland
5Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
6Skåne University Hospital, Lund, Sweden
7Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
9The Binding Site Inc., Birmingham, United Kingdom
10Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Salyka M. Sengsayadeth, MD1*, Bridget Fitzgerald2*, Bharat Nandakumar3*, Bicky Thapa, MD4*, Timothy Martin Schmidt, MD5, Rebecca Silbermann, MD, MMS6, Heidi Chen, PhD7*, Saurabh Chhabra, MD, MS8, Natalie Callander, MD9, Shaji K Kumar, MD10 and Luciano J. Megala Costa, MD, PhD11

1Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
2Vanderbilt University Medical Center, Nashville, TN
3Mayo Clinic, Rochester, MN
4Medical College of Wisconsin, Milwaukee, WI
5University of Wisconsin Carbone Cancer Center, Madison, WI
6School of Medicine Oregon Health and Science University, Portland, OR
7Vanderbilt Ingram Cancer Center, Nashville, TN
8Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
9University of Wisconsin, Madison, WI
10Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
11University of Alabama at Birmingham Hospital, Vestavia, AL

Sheena Sharma1,2*, Diane Wang1*, Hoi-Kei Lon1*, Pooneh Soltantabar1*, Andrea Viqueira, MD3*, Akos Czibere4*, Anne Hickman5*, Jane Liang White, ScD4* and Mohamed Elmeliegy, PhD1*

1Global Product Development, Pfizer Inc, San Diego, CA
2Department of Pharmaceutical Sciences, Washington State University, Spokane, WA
3Pfizer SLU, Madrid, Spain
4Global Product Development, Pfizer Inc, Cambridge, MA
5Global Product Development, Pfizer Inc, Groton, CT

John D Cooper, MD1*, Jennifer A Thornton, PhD2*, Steven J Gibson, MD3*, Kevin Pham4*, Kevin Sunderland4* and Christin B DeStefano, MD5

1Walter Reed National Military Medical Center, Bethesda, MD
2Clinical Investigation Facility, David Grant USAF Medical Center, Fairfield, CA
3Internal Medicine Residency Program, National Capital Consortium, Bethesda, MD
4David Grant USAF Medical Center, Fairfield, CA
5Hematology/Oncology, Walter Reed National Military Medical Center, Bethesda, MD

Ayrton Bangolo1*, Samir Oza, MBS, BS2*, Ronit Slotky, PhD, MSc2*, Aimee Chappell3*, David Samuel Siegel, MD, PhD4,5,6,7,8,9,10,11, Harsh Parmar, MD12*, Noa Biran, MD6,13,14,15,16, David H. Vesole, MD, PhD17 and Pooja Phull, MD2

1Hackensack Meridian Health/Palisades Medical Center, Edgewater, NJ
2John Theurer Cancer Center/Hackensack University Medical Center, Hackensack, NJ
3Medstar Georgetown University Hospital Department of Hematology/Oncology, Washington
4Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health and Center for Discovery and Innovation, Hackensack, NJ
5Hackensack University John Theurer Cancer Center, Hackensack, NJ
6John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
7John Theurer Cancer Center, Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ
8111 Ideation Way, Center for Discovery & Innovation, Nutley, NJ
9Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
10John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
11Hackensack University Medical Center, Hackensack, NJ
12Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ
13Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
14John Theurer Cancer Center, Hackensack Meridian Health, Division of Multiple Myeloma, Hackensack, NJ
15John Therurer Cancer Center at Hackensack University, Hackensack, NJ
16Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Tenafly, NJ
17Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ, Hackensack, NJ

Anup Joseph Devasia, MD, DM1*, Sahar Khan, FRCPath, MD2*, Harminder K Paul, MSc3*, Frédéric Larose, MD4*, Eshetu G. Atenafu, M.Sc., P.Stat5,6*, Donna E. Reece, MD, FRCPC7, Suzanne Trudel, MD7*, A. Keith Stewart, MBChB8, Sita Bhella, M.D., MSc3*, Vishal Kukreti, MD, FRCP, MSc9, Chloe Yang, MD3*, Rodger E Tiedemann, MBChB, PhD8, Anca Prica, MD, MSc10*, Monica Monchis7*, Eugene Leung7*, Susan Jomah7*, Zubaida Mohamed7* and Christine Chen, MHPE, MD, FRCPC11*

1Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
2Windsor Regional Cancer Centre, Windsor, ON, CAN
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
4Hotel-Dieu-de-Levis hospital, Québec, QC, Canada
5Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
6Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
7Princess Margaret Cancer Centre, Toronto, ON, Canada
8Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
9University Health Network, Princess Margaret Hospital, Toronto, ON, Canada
10University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
11Princess Margaret Cancer Center, Toronto, Canada

Anas Al Zubaidi, MD1*, Abdul Rahman Al Armashi, MD2*, Dina Elantably, MD3*, Jiasheng Wang, MD2 and Akram Alkrekshi, MD4*

1Johns Hopkins University, Baltimore, MD
2Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
3Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Cleveland, OH
4Department of Internal Medicine, Case Western Reserve University MetroHealth Medical Center, Westlake, OH

Pierre-Edouard Debureaux, MD1*, Stephanie Harel, MD1*, Nathalie Parquet, MD2*, Virginie Lemiale, MD3*, Virginie Siguret, PhD4*, Laurie Goubeau4*, Florence Morin, MD5*, Bruno Royer, MD1*, Wendy Cuccuini, MD, PhD6*, Dikelele Elessa, MD1*, Floriane Theves, MD1*, Anne Brignier, MD2*, Elie Azoulay, MD PhD3,7*, Bertrand Arnulf7,8* and Alexis Talbot, MD1,7*

1Immuno-Hematology, Saint Louis Hospital, Paris, France
2Therapeutic Apheresis Unit, Saint Louis Hospital, Paris, France
3ICU Unit, Saint Louis Hospital, Paris, France
4Hematology Laboratory, Lariboisière Hospital, Paris, France
5Laboratory of Immunology, Saint Louis Hospital, APHP, University of Paris, Paris, France, Paris, France
6Hematology Laboratory APHP and INSERM U944, Saint Louis Hospital, PARIS, FRA
7University of Paris Cité, Paris, France
8Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France

Ping Zhou, MD, PhD1*, Mahesh M Mansukhani, MD2*, Denis Toskic, BS3*, Stephanie Scalia, MS3*, Lisa Lee, MD4*, Sandy W. Wong, MD5, Sascha A. Tuchman, MD, MHS6, James E. Hoffman, MD7*, Teresa Fogaren, NP1*, Cindy Varga, MD, BSc8, Suzanne Lentzsch, MD, PhD9* and Raymond Comenzo, MD1

1Tufts Medical Center, Boston, MA
2Columbia University Medical Center, New York, NY
3John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
4Chao Family Comprehensive Cancer Center, UC Irvine, Orange, CA
5Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
6Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
7Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
8Levine Cancer Institute, Charlotte, NC
9Medical Oncology, Columbia University Medical Center, New York, NY

Gary J. Schiller, MD1, Sascha A. Tuchman, MD, MHS2, Natalie Callander, MD3, Muhamed Baljevic, MD4, Adrianna C Rossi, MD5*, Rami Kotb, MD, FRCPC6, Darrell J White, MD7, Nizar J. Bahlis, MD8, Heather J. Sutherland, MD, PhD, FRCPC9, Sumit Madan, MD10, Richard Leblanc, MD, FRCPC11, Christopher P. Venner, MD12, William I. Bensinger, MD13*, Dane R. Van Domelen, PhD14*, Chris Zhang, MD14*, Ohad S. Bentur, MD MHA14 and Brea Lipe, MD15

1UCLA David Geffen School of Medicine, Los Angeles, CA
2University of North Carolina, Chapel Hill, NC
3University of Wisconsin Carbone Cancer Center, Madison, WI
4University of Nebraska Medical Center, Omaha, NE
5NYPH Weill Cornell, New York, NY
6Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
7Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
8Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
9Division of Hematology, Vancouver General Hospital, Vancouver, BC, Canada
10Banner MD Anderson Cancer Center at Banner University Medical Center, Phoenix, AZ
11Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
12University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
13Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
14Karyopharm Therapeutics Inc., Newton, MA
15The Department of Medicine, University of Rochester Medical Center, Rochester, NY

Jing Dong, PhD1, Jian-Rong Li, phD2*, Christopher Staffi Buradagunta, MS3*, Siegfried Janz1, Raul Urrutia, MD4* and Chao Cheng2,5*

1Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Medicine, Baylor College of Medicine, Houston, TX
3Medicine, MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
4Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI
5Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX

Hongying You, MD1*, Song Jin, MD, PhD1*, Chunxiao Wu, MD1*, Qingqing Wang, MD1*, Shuang Yan, MD1*, Yingying Zhai, MD1*, Weiqin Yao, MD1*, Xiaolan Shi, MD, PhD1*, Jingjing Shang, MD, PhD1*, Lingzhi Yan, MD, PhD2*, Ying Yao, MD3*, Jing Wang, MD3*, Panfeng Wang, MD3*, Jinlan Pan, MD1*, Depei Wu1 and Chengcheng Fu, MD, PhD1*

1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
2Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
3Soochow Hopes Hematonosis Hospital, Suzhou, China

Katie Dunphy1*, Despina Bazou, BSc, MSc, PhD2*, Paul Dowling, BSc, PhD1* and Peter O'Gorman, MD, PhD, FRCP, FRCPath2

1Biology Department, Maynooth University, Co. Kildare, Ireland
2Department of Hematology, Mater Misericordiae University Hospital, Dublin 7, Ireland

Naseem S Esteghamat, MD1, Ann M Brunson, MS2*, Ted Wun, MD3, Aaron S Rosenberg, MD1, Julianne J.P. Cooley, MS4*, Sara J. Schonfeld5*, Christa L. Meyer, MS6*, Bryan Valcarcel, MD5*, Renata Abrahao, MD, PhD, MSc7, Jeffery Auletta, MD8,9, Lindsay M. Morton, PhD5, Lori Muffly, MD10 and Theresa H.M. Keegan, PhD7

1Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
2Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
3UC Davis Comprehensive Cancer Center, Sacramento, CA
4California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA
5Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
6CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
7Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
8Center for International Bone Marrow Transplant Registry/National Marrow Donor Program/Be the Match, Minneapolis, MN
9Nationwide Children's Hospital, Columbus, OH
10Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA

Ben Massat, DO1*, Gokul Pareek2*, Christopher Staffi Buradagunta2*, Bicky Thapa, MD3*, Paul Auer, phD4*, Binod Dhakal, MBBS5, Siegfried Janz6, Parameswaran Hari, MD, MRCP3 and Jing Dong, PhD6

1Medicine, Medical College of Wisconsin, Milwaukee, WI
2MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
3Medical College of Wisconsin, Milwaukee, WI
4Division of Biostatistics, Institute for Health & Equity, and Cancer Center, MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
5Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
6Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

W. Cliff Rutter, PharmD, PhD1*, Elisea Avalos-Reyes, PhD1*, Will Cavers, MSc1*, Shivaani Prakash, MSc, PhD1*, Kjel Johnson, PharmD1* and Leon Bernal-Mizrachi, MD2

1CVS Health, Lincoln, RI
2Winship Cancer Institute/Department of Hematology and Medical Oncology, Emory University, Brookhaven, GA

Andrea Angioi, MD1*, Moritz Binder, MD2, Nelson Leung, MD3,4, Frank Bridoux, MD, PhD5*, Camille Cohen6*, David Dingli, MD, PhD2, Angela Dispenzieri, MD2, Parikshit Duriseti, MD3*, Roberta Fenoglio7*, Amie Fonder, PA-C2*, Morie A. Gertz, MD, MACP2, Ronald Go, MD2, Wilson I. Gonsalves, MD2, Suzanne R. Hayman, MD2, Miriam A. Hobbs, APRN, CNP, DNP2*, Yi L. Hwa, NP2, Prashant Kapoor, MD2, Bertrand Knebelmann8*, Taxiarchis Kourelis, MD2, Shaji K Kumar, MD2, Robert A. Kyle, MD9, Martha Q. Lacy, MD10, Nicola Lepori1*, Yi Lin, MD, PhD2, Shveta Motwani, MD11*, Eli Muchtar, MD2, Samih Nasr, MD12*, Antonello Pani13*, Dario Roccatello14*, Virginie Royal, MD15*, Paul Sanders16*, Stephan Troyanov, MD17*, Christopher P. Venner18*, Rahma M Warsame, MD2, Niloufarsadat Yarandi, MD19* and S. Vincent Rajkumar, MD2*

1Azienda Ospedaliera G. Brotzu, Cagliari, ITA
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
5Nephrology and Transplant Unit, CHU Poitiers, Poitiers, France
6Necker Hospital, Paris, FRA
7S. Giovanni Bosco Hospital and University of Turin, Turino, ITA
8Service de Néphrologie, Necker hospital, Paris, France
9Division of Hematology, Mayo Clinic, Stabile 6-28, Rochester, MN
10Division of Hematology, Mayo Clinic Rochester, Rochester, MN
11Division of Nephrology, Dana Farber Cancer Institute, Boston, MA
12Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
13Divisione di Nefrologia e Dialisi, Azienda Ospedaliera G. Brotzu, Cagliari, ITA
14Nephrology and Dialysis Unit, S. Giovanni Bosco Hospital and University of Turin, Turin, ITA
15Division of Pathology, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, QC, CAN
16University of Alabama At Birmingham, Birmingham, AL
17Division of Nephrology, Hôpital du Sacré-Cœur, Université de Montréal, Montreal, QC, Canada
18Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
19Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, CT

Zhengyu Yu, PhD1*, Linfeng Li2*, Jin Xu, PhD1*, Hui Zhou, PhD1* and Ting Niu1,3

1Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China
2Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
3State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Guido Lancman, MD, MSc1,2, Kian Parsa, DO3*, Cesar Rodriguez, MD1, Joshua Richter, MD1, Hearn J. Cho, MD, PhD1, Samir Parekh, MD1, Shambavi Richard, MD1, Adriana Rossi, MD, MSc1, Larysa Sanchez, MD1, Santiago Thibaud, MD1, Sundar Jagannath1 and Ajai Chari, MD1

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
3Icahn School of Medicine at Mount Sinai, New York, NY

Dr. Maryam Alomran, MD1*, Cameron Wellard, PhD2*, Pin-Yen Chen, BBiomedSc (Hons), PhD3*, Elizabeth M. Moore, PhD3* and Wee Joo Chng, MBChB PhD4

1Hematology, NUH singapore, Salmaniya, AL, Bahrain
2School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
3Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
4National University Cancer Institute, Singapore, Singapore

Timothy Martin Schmidt, MD1, Rebecca Silbermann, MD, MMS2, Susan Bal, MD3, Binod Dhakal, MBBS4, Bhagirathbhai Dholaria, MBBS5, Eden Biltibo, MD, MS6, Saurabh Chhabra, MD, MS7, Smith Giri, MD, MHS8, Kelly N. Godby, MD9*, Sonia Gowda, MD10*, Eva Medvedova, MD2, Natalie Callander, MD11 and Luciano J. Megala Costa, MD, PhD3

1Carbone Cancer Center, University of Wisconsin, Madison, WI
2Knight Cancer Institute, Oregon Health and Science University, Portland, OR
3University of Alabama at Birmingham, Birmingham, AL
4Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
5Vanderbilt University Medical Center and Vanderbilt- Ingram Cancer Center, Nashville, TN
6Vanderbilt University Medical Center, Nashville, TN
7Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
8Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
9Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
10Department of Internal Medicine, Oregon Health and Science University, Portland, OR
11University of Wisconsin Carbone Cancer Center, Madison, WI

Andrew Gahagan, MD1, Sunil Rangarajan, MD, MBBS2, Clare Ubersax, BS3*, Abigail Tucker, MSPH3*, Christian Harmon, MD3*, Monica Sai Pasala, BS4*, Susan Bal, MD5, Kelly N. Godby, MD6*, Gayathri Ravi, MD6, Luciano J. Megala Costa, MD, PhD7, Grant Williams, MD, MPH2*, Smita Bhatia, MD, MPH3 and Smith Giri, MD, MHS3

1University of Alabama at Birmingham Hospital, Birmingham, AL
2Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
3Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
4School of Medicine, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL
6Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
7University of Alabama at Birmingham Hospital, Vestavia, AL

Brian Hoeynck, MD1, Wei-Ting Hwang2*, Alfred L Garfall, MD3, Sandra Patricia Susanibar-Adaniya, MD3*, Dan T. Vogl, MD3, Adam Waxman, MD3, Edward A. Stadtmauer, MD3 and Adam D Cohen, MD4

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4University of Pennsylvania, Philadelphia, PA

Luciano J. Megala Costa, MD, PhD1, Kelly N. Godby, MD2*, Gayathri Ravi, MD3*, Smith Giri, MD, MHS4 and Susan Bal, MD5

1University of Alabama at Birmingham Hospital, Vestavia, AL
2Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
3Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL
4Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL

Murielle Roussel, MD1,2,3*, Michelle Pirotte, MD1,4,5*, Ornella Rizzo, MD1,4,6*, Kentin Queru1,4*, Thomas Chalopin, MD7*, Olivier Decaux, MD, PhD8,9*, Estelle Desport, MD10,11*, Frank Bridoux, MD, PhD3,10,11* and Arnaud Jaccard1,3,4*

1CHU of Limoges and Poitiers, French National Reference Center for AL amyloidosis and monoclonal immunoglobulin deposition diseases, Limoges, France
2CHU Dupuytren, Department of Hematology and Cellular Therapy, Limoges Cedex 1, France
3CRIBL Lab, UMR CNRS 7276, INSERM U1262, Limoges, France
4CHU Dupuytren, Department of Hematology and Cellular Therapy, Limoges, France
5Department of Hematology, CHU Sart-Tilman and University of Liège, Liège, Belgium
6Brussels, Brussels, BEL
7Department of Hematology and Cellular Therapy, Tours University Hospital, UMR CNRS, François Rabelais University, Tours, France
8Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
9Université de Rennes 1, INSERM, Établissement Français du Sang de Bretagne, Unité Mixte de Recherche (UMR)_S1236, Rennes, France
10Nephrology and Transplant Unit, CHU Poitiers, Poitiers, France
11CHU of Limoges and Poitiers, French National Reference Center for AL amyloidosis and monoclonal immunoglobulin deposition diseases, Poitiers, France

Limei Zhang1*, Yun Wang, MD, PhD2*, Robert Peter Gale3 and Yang Liang, MD, PhD2

1Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
3Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

Medha Reddy Cherabuddi, MBBS1*, Kathren Shango, MD1*, Swetha Reddi, BS1*, Pin Li, PhD2* and Vijaya Donthireddy, MD3

1Internal Medicine, Henry Ford Hospital, Detroit, MI
2Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI
3Hematology and Oncology, Henry Ford Hospital, Detroit, MI

Jeremy A. Ross, PhD1*, Herve Avet-Loiseau, MD, PhD2*, Xiaotong Li, PhD3*, Raphaele Thiebaut-Millot, PhD3* and Carlos Hader, PhD1*

1AbbVie, Inc., North Chicago, IL
2Universite Paul Sabatier, Toulouse, FRA
3AbbVie Inc., North Chicago, IL

Andrew R. Branagan, MD1, Matthew M Lei, PharmD1*, Clifton C Mo, MD2*, Andrew J. Yee, MD1, Elizabeth K. O'Donnell, MD1, Jorge J. Castillo, MD2, Omar Nadeem, MD3, Noopur Raje, MD1, Steven P Treon, MD, PhD2, Paul G. Richardson, MD2, Rie Nakamoto-Matsubara, MD, PhD1*, Kirsten Meid, MPH2*, Zachary S. Bernstein1*, Rebecca T. Lyons1*, Rakesh Verma, PhD1*, Zachary R Hunter, PhD2, Maria Luisa Guerrera, MD2, Catherine A. Flynn, NP2*, Jill N. Burke, NP1*, Cynthia C. Harrington, NP1*, Emerentia Agyemang, NP1*, Marilyn T. Gammon, RN1*, Kathleen J. Lively, RN1*, Lisette Packer, RN1*, Nora K. Horick, MS1* and Shayna Sarosiek, MD4

1Massachusetts General Hospital Cancer Center, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

Wenjing Wang, MD*, Jing Li, MD*, Yang Yang, MD*, Feifei Chen, MD, PhD*, Tianhong Xu, MD*, Pu Wang*, Yawen Wang*, Aziguli Maihemaiti*, Liang Ren* and Peng Liu, MD

Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China

Ástrún Helga Jónsdóttir1*, Sæmundur Rögnvaldsson, MD1,2*, Helga Ágústa Sigurjónsdóttir2,3*, Sigrún Thorsteinsdóttir, MD, PhD3,4, Brynjar Vidarsson, MD2, Páll Torfi Onundarson, MD2,3, Bjarni Agnarsson, MD2,3*, Margrét Sigurdardóttir, MD2*, Ingunn Thorsteinsdóttir, MD, PhD2*, Ísleifur Ólafsson, MD, PhD2*, Signy Vala Sveinsdottir, MD2*, Robert Palmason2,5*, Ásdis Rósa Thórdardottir3*, Elias Eythorsson, MD, PhD2*, Asbjorn Jonsson, MD2,6*, Runolfur Palsson, MD2,3*, Olafur Skuli Indridason, MD, MHS2,3*, Gauti Kjartan Gislason, MSc3*, Andri Olafsson3*, Jon Kristinn Sigurdsson3*, Ingigerdur S Sverrisdottir, MD2,3,7*, Thorir Einarsson Long, MD, PhD3,5*, Thor Aspelund, PhD3*, Malin Hultcrantz, MD, PhD8, Brian G.M. Durie, MD9, Stephen Harding, PhD10, Ola Landgren, MD11, Thorvardur Jon Love, MD, PhD2,3* and Sigurdur Y Kristinsson, MD, PhD2,3

1Faculty of Medicine, University of Iceland, Reykjavík, Iceland
2Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
3Faculty of Medicine, University of Iceland, Reykjavik, Iceland
4Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
5Skåne University Hospital, Lund, Sweden
6Akureyri Hospital, Akureyri, Iceland
7Sahlgrenska University Hospital, Gothenburg, Sweden
8Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sloan Kettering Cancer Center, New York, NY
9Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
10The Binding Site Inc., Birmingham, United Kingdom
11Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Habib El-Khoury, MD1,2, Luca Bertamini, MD1,2*, Jean-Baptiste Alberge, PhD1,2,3*, David J. Lee, MD1,3,4,5, Ciara Murphy1,2*, Grace Fleming, BS1,2*, Christian J. Cea-Curry, BS1,2*, Maya I. Davis, BA1,2*, Jacqueline Perry, MPH1,2*, Elizabeth D. Lightbody, PhD1,2,6, Dhananjay Sakrikar, PhD7*, Derek Troske, BS7*, David Barnidge, PhD7*, Mark C. Perkins, PhD8*, Stephen Harding, PhD8, Gad Getz, PhD1,6,9*, Catherine R. Marinac, PhD1,2,10 and Irene Ghobrial, MD1,2,6

1Harvard Medical School, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Medicine, Massachusetts General Hospital, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
6Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
7The Binding Site Inc., Rochester, MN
8The Binding Site Inc., Birmingham, United Kingdom
9Center for Cancer Research, Massachusetts General Hospital, Boston, MA
10Harvard T.H. Chan School of Public Health, Boston, MA

Beatrice Fregonese, MPH1*, Alexandra Dreyfuss, MD2*, Jisun Lee3*, Brandon S. Imber, MD3, Joachim Yahalom, MD3 and Carla Hajj, MD3*

1Memorial Sloan Kettering Cancer Center, New York City, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Ieuan Walker, MBBS, MSc, BSc, MRCP1*, Venetia D'arcy, MBBS, BSc, MRCP1*, Antonio Rodriguez Romera, BSc.1*, Georgina Anderson, BSc, PhD1*, Anna Aubareda, PhD2*, James Roy, BSc, PhD.1*, Garima Khandelwal3*, William Wilson4*, Evelyn Fitzsimons, BSc5*, Daria Galas-Filipowicz6*, Kane Foster, BSc.3*, Rakesh Popat3,7*, Karthik Ramasamy8, Matthew Streetly, MD9, Ceri Bygrave10*, Reuben Benjamin, MD, PhD11, Ruth M. de Tute12*, Marquita Camilleri13*, Selina J Chavda, MBBS, BSc, MRCP, FRCPATH5*, Gavin Pang14*, Tushhar Dadaga, BSc14*, Sumaiya Kamora, BSc14*, James Cavenagh, MD15,16, Elizabeth H. Phillips17*, Laura Clifton-Hadley, BSc, PhD18*, Roger G Owen19*, Javier Herrero, PhD20*, Kwee Yong21,22* and Michael A Chapman, PhD, MRCP, FRCPath1

1MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom
2University of Cambridge, Cambridge, GBR
3Cancer Institute, University College London, London, United Kingdom
4UCL Cancer Trials Centre, London, United Kingdom
5Cancer Institute, Department of Haematology, University College London, London, United Kingdom
6Cancer Institute, Department of Haematology, UCL, London, United Kingdom
7University College London Hospitals NHS Foundation Trust, London, United Kingdom
8Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
9Department of Haematology, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom
10Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
11Department of Haematology, King’s College Hospital, London, United Kingdom
12Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom
13Haematology, Addenbrookes Hospital, Cambridge, United Kingdom
14Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
15Department of Haematology, Barts Health NHS Trust, London, United Kingdom
16Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
17Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
18Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
19St. James's University Hospital, Leeds, United Kingdom
20Cancer Institute, Bill Lyons Informatics Centre, University College London, London, United Kingdom
21Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
22Department of Haematology, University College Hospital, London, United Kingdom

Thorir Einarsson Long, MD, PhD1,2,3*, Elias Eythorsson, MD, PhD4*, Sæmundur Rögnvaldsson, MD5,6*, Olafur Indridason, MD, MHS7*, Runolfur Palsson, MD6,8*, Sigrún Thorsteinsdóttir, MD, PhD8,9, Ingigerdur S Sverrisdottir, MD6,8,10*, Thor Aspelund, PhD8*, Brynjar Vidarsson, MD6, Páll Torfi Onundarson, MD6,8, Bjarni Agnarsson, MD6,8*, Margrét Sigurdardóttir, MD6*, Ingunn Thorsteinsdottir, MD6*, Ísleifur Ólafsson, MD, PhD6*, Asdis Rosa Thordardottir11*, Asbjorn Jonsson, MD6*, Gauti Kjartan Gislason, MSc8*, Andri Olafsson8*, Hlif Steingrimsdottir, MD6*, Malin Hultcrantz, MD, PhD12, Brian G.M. Durie, MD13, Stephen Harding, PhD14, Ola Landgren, MD15, Thorvardur Jon Love, MD, PhD6,8* and Sigurdur Y Kristinsson, MD, PhD6,8

1Landspitali University Hospital, Reykjavik, Iceland
2Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
3Skåne University Hospital, Lund, Sweden
4Landspitali - The National University Hospital of Iceland, Reykjavík, AL, Iceland
5Faculty of Medicine, University of Iceland, Reykjavík, Iceland
6Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
7Landspítali-The National University Hospital of Iceland, Reykjavik, ISL
8Faculty of Medicine, University of Iceland, Reykjavik, Iceland
9Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark
10Sahlgrenska University Hospital, Gothenburg, Sweden
11University of Iceland, Reykjavik, ISL
12Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
14The Binding Site Inc., Birmingham, United Kingdom
15Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Ali Abdelhay, md1, Amir Mahmoud, MD1*, Simrat Gill, MD2*, Omar Al Ali, MD3*, Mohamed Salah Mohamed, MD3*, Anas Hashem, MD3*, Ahmed Shehadah, MD3*, Basant Eltaher, MD4*, Suhib Fahmawi, MD5*, Mariam Haji, MD6* and Mariam Mostafa, MD3*

1Rochester General Hospital, Rochester, NY
2Division of Internal Medicine, Rochester General Hospital, Rochester, NY
3Rochester General Hospital, Rochester N.Y, NY
4Department if Hematology and Bone Marrow Transplant, Faculty of Medicine, Ain Shams University, Cairo, Egypt
5East Tennessee State University - Quillen College of Medicine, Johnson City, TN
6University of Missouri-Kansas City, Kansas city, MO

Syed Arsalan Ahmed Naqvi, MBBS1*, Sarosh Fatima, M.B.B.S2*, Noureen Asghar3*, Hafsah Ijaz, M.B.B.S.4*, Ahsan Ayaz, M.D.5*, Huan He, Ph.D.6*, Muhammad Husnain, MD7*, Rajshekar Chakraborty, MD8, Irbaz Riaz, MD, MMSc9 and Mohammed A. Aljama, M.D.10*

1Division of Hematology and Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ
2Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
3Creighton University, Omaha, NE
4Nishtar Medical University, Multan, Pakistan
5Mayo Clinic, Phoenix, AZ
6Mayo Clinic, Rochester, MN
7University of Arizona Cancer Center, Division of Hematology and Medical Oncology, Tucson, AZ
8Hematology and Medical Oncology, Columbia University, Irving Medical Center, New York, NY
9Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
10McMaster University, Hamilton, ON, Canada

Linda B. Baughn, Ph.D1, Elizabeth S. Mearns, PharmD2*, Michael Nixon, MSN, MPH2*, Vivek S. Chopra, PhD3*, Allicia Girvan, PhD4*, R. Frank Cornell, MD4, Jayeta Saxena, PhD5*, Bethany M. Slifko, MBA, MLS (ASCP)cm5*, Jordan Clark, MPhil5* and Shaji K Kumar, MD1

1Mayo Clinic, Rochester, MN
2Genentech, Inc., South San Francisco, CA
3Genentech, Inc., San Francisco, CA
4AbbVie, Inc., North Chicago, IL
5Diaceutics PLC, Belfast, United Kingdom

Faris Jamal Abu Za'nouneh, MD1*, Obada Ababneh2*, Carolina Schinke3,4, Sharmilan Thanendrarajan, MD3,4, Maurizio Zangari, MD3,4,5, John D Shaughnessy Jr., PhD6*, Fenghuang Zhan, MD, PhD4, Frits van Rhee3 and Samer Al Hadidi, MD, MSc4,7

1Faculty of Medicine, Jordan University Of Science and Technology, Irbid, GA, Jordan
2Jordan University Of Science and Technology, Irbid, JOR
3Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
4Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
5Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
6Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR
7Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Yanying Yu1*, Xuemin Gao, MD1*, Hao Zhao, MD1*, Anan Li, MD1*, Hao Cai2*, Jun Feng, MD1*, Lu Zhang, MD1*, Xinxin Cao, MD1* and Jian Li, MD1

1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Department of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College,Peking Union Medical College Hospital,, Beijing, China

Stephanie Scalia, MS1*, Denis Toskic, BS1*, Ping Zhou, MD, PhD2*, Mahesh M Mansukhani, MD3*, Lisa Lee, MD4*, Sandy W. Wong, MD5, Sascha A. Tuchman, MD, MHS6, James E. Hoffman, MD7*, Teresa Fogaren, NP2*, Cindy Varga, MD8*, Suzanne Lentzsch, MD, PhD9* and Raymond Comenzo, MD2

1John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
2Tufts Medical Center, Boston, MA
3Columbia University Medical Center, New York, NY
4Chao Family Comprehensive Cancer Center, UC Irvine, Orange, CA
5Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
6Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
7Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami
8Levine Cancer Institute, Charlotte, NC
9Medical Oncology, Columbia University Medical Center, New York, NY

Mohamed A Badawi, PhD1*, Benjamin Engelhardt, PhD2*, Jesus Badillo, PhD2*, Ahmed Abbas Suleiman, PhD2*, Leanne Lash Fleming, PhD3*, Yan Luo, MD, PhD3*, Jonathan L. Kaufman, MD4, Nizar Jacques Bahlis, MD5, Rajeev Menon, PhD1* and Ahmed Hamed Salem, PhD, FCP1

1Clinical Pharmacology, AbbVie Inc., North Chicago, IL
2Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, IL, Germany
3AbbVie Inc., North Chicago, IL
4Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
5Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada

Malin Hultcrantz, MD, PhD1, David Kleinman, MD2*, Ravi Vij, MD3, Fernando Escalante, MD4*, Nirali Kotowsky, MPH5*, Jacopo Bitetti, MD6*, Christine Mackay, PhD5*, Natalie Boytsov, PhD5*, Leena Camadoo-O'Byrne, MSc7*, Guillaume Germain, MSc8*, Mei Sheng Duh, ScD, MPH9, François Laliberté10*, Malena Mahendran, MSc11*, Ana Urosevic, MA12* and Hans C. Lee, MD13

1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY
3Washington University, St Louis, MO
4Hematology Department, University Hospital of León, León, Spain
5GSK, Upper Providence, PA
6GSK, Zug, Switzerland
7GSK, Stevenage, United Kingdom
8Groupe d’Analyse, Ltée, Montréal, QC, Canada
9Analysis Group, Inc., Boston, MA
10Groupe d’analyse, Ltée, Montréal, QC, Canada
11Groupe d’Analyse, Ltée, Montreal, Canada
12Groupe d’Analyse, Ltée, Montreal, QC, Canada
13Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH